Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.

MLA

Vogel, Birgit, et al. “Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.” JAMA Cardiology, vol. 6, no. 9, Sept. 2021, pp. 1032–41. EBSCOhost, https://doi.org/10.1001/jamacardio.2021.1720.

APA

Vogel, B., Baber, U., Cohen, D. J., Sartori, S., Sharma, S. K., Angiolillo, D. J., Farhan, S., Goel, R., Zhang, Z., Briguori, C., Collier, T., Dangas, G., Dudek, D., Escaned, J., Gil, R., Han, Y.-L., Kaul, U., Kornowski, R., Krucoff, M. W., … Mehran, R. (2021). Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. JAMA Cardiology, 6(9), 1032–1041. https://doi.org/10.1001/jamacardio.2021.1720

Chicago

Vogel, Birgit, Usman Baber, David J Cohen, Samantha Sartori, Samin K Sharma, Dominick J Angiolillo, Serdar Farhan, et al. 2021. “Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.” JAMA Cardiology 6 (9): 1032–41. doi:10.1001/jamacardio.2021.1720.